Form D · Private Equity Fund
ABG-SIV II, L.P.
Grand Cayman, E9 · CIK 0002116445
Offering snapshot reported Mar 11, 2026 · SEC filing
- Reported sold
- $1M Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 13, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 11, 2026 | Initial | $1,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-576120
Source: Form D, filed Mar 11, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Abg Global Life Science Capital Partners V Gp, L.P. | Promoter |
| Shan Ju Yeh | Director |
| Fan Yu | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
Maples Corporate Services Limited Ugland House
Grand Cayman, E9, KY1-1104
Grand Cayman, E9, KY1-1104